Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 359

COVID Susceptibility Index can help to manage outbreaks

Background: At a recent UNSW virtual research seminar, Calise Liu and Alan Xian presented their research on developing a COVID-19 Susceptibility Index. This interview explores the research and its potential applications. Calise works at Finity Consulting, which specialises in actuarial and strategic analytics consulting. Alan has nearly finished his PhD at UNSW and will start a role at Macquarie University later this year. 

David: With your actuarial backgrounds, what motivated you to get involved in COVID-19 research, which to many is the domain of medical researchers?

Calise: Once you have data (and there is a lot of data available), many of the skills required to analyse that data are universal. We had read a lot of medical literature but hadn’t seen the translation of those results to the Australian population. Actuaries are particularly well-placed because we have expertise in modelling large demographic data sets. Of course, we are not medical experts and so we made sure to get specialist medical input. We held discussions with six medical experts on the design aspects of our research.

David: Why the focus on susceptibility?

Alan: There was already a lot of research modelling transmission of the virus. We noticed a research gap in terms of investigating susceptibility at a demographic level. Susceptibility, the risk of severe illness or death if an individual were to contract the virus, is important in many ways. At a government level, susceptibility tells you how bad it could be in each region if an outbreak were to occur. This then informs decisions around resource allocation and how quickly you want to be able to identify and treat known cases.

David: Explain how you have developed the Susceptibility Index.

Alan: We combined age characteristics (60-69, 70-79, and 80+) with five health aspects (known as co-morbidities): cardiovascular disease, respiratory disease, cancer, diabetes and obesity. Unfortunately, the data shows that certain groups – notably the elderly with multiple health issues – are many times more likely to have severe reactions if infected with COVID-19, compared with young healthy people.

Calise: By combining our susceptibility score with Finity’s Defin’d dataset of socio-demographic and geographic attributes, we can explore COVID-19 impacts by area, household composition, income band, industry and more. We found some evidence of vulnerable populations away from capital cities, where multiple risk factors are more concentrated. We used heatmaps to visualise the susceptibility risk (red indicates areas with, on average, highest susceptibility).

The news is both good and bad. So far, most of the cases have occurred in areas with relatively-lower susceptibility. However, this is something to consider when looking at when, where and how to relax restrictions.

David: When you combine the demographic data with age and health factors, do any socio-economic effects emerge?

Alan: Unfortunately, we find that at-risk communities commonly have low socio-economic characteristics (i.e. low income). This isn’t surprising – when we spoke to our medical experts, they were aware that health issues and co-morbidities tend to present more strongly in poorer socio-economic groups. As a result, the disadvantaged segments of Australia may require additional resources as we start relaxing isolation measures.

David: What are the implications for government policy?

Calise: We think our work can inform policy in a number of ways. Our model provides an exposure measure for the Australian population that can serve as a foundation for various extensions. Transmission information can be overlaid to assess the impact of various policies. Our analysis can also highlight areas where outbreaks of COVID-19 may be particularly devastating, guiding decisions around allocation of financial and medical resources. Conversely, the additional economic information could be incorporated to examine trade-offs between simulating economic recovery and minimising risk to public safety.

David: I know this is early days, but have you been able to share this research with authorities?

Alan: We have had some interest from the Department of Health. We are happy to work with any interested parties to see how our work could be of assistance.

David: Finally, Alan, you’ve effectively put your PhD on hold, and Calise, you’ve been supported by Finity, but most of this research is outside of work hours. Do you think that this may be a feature of your future careers, jumping into projects outside your core line of research where you see the opportunity to contribute?

Calise: I think many young people view contribution as an important part of their career. I’m fortunate to have an analytical skillset which can be applied to different problems. 

Alan: I do have to finish my PhD soon and am looking forward to that light at the end of the tunnel. Luckily, I have supportive supervisors who share my view that these contributions are worthwhile pursuits. At the start of my PhD, what I really wanted was to produce societally beneficial research and so these projects are very exciting. 

 

Individuals with co-morbidities or symptoms associated with COVID-19 should follow the government advice and take extra precautions which can be found here.

If you would like to know more about the Susceptibility Index you can read more here.

 

David Bell is Executive Director of The Conexus Institute, a not-for-profit research institution focused on improving retirement outcomes for Australians. Calise Liu is a Fellow of the Institute of Actuaries of Australia and an intern at Finity Consulting. Alan Xian is a PhD candidate at UNSW.

 


 

Leave a Comment:

     

RELATED ARTICLES

Baby bust: will infertility shape Australia's future?

Four ethical challenges in exiting Covid-19 rules

The demographics of a growing (and ageing) Australia

banner

Most viewed in recent weeks

Three steps to planning your spending in retirement

What happens when a superannuation expert sets up his own retirement portfolio using decades of knowledge? He finds he can afford much more investment risk in his portfolio than conventional thinking suggests.

Finding sustainable dividend stocks on the ASX

There is a small universe of companies on the ASX which are reliable dividend payers over five years, are fairly valued and are classified as ‘negligible’ or ‘low’ on both ESG risk and carbon risk.

Among key trends in Australian banks, one factor stands out

The Big Four banks look similar but they are at fundamentally different stages as they move to simpler business models. Amid challenges from operating systems, loan growth and neobank threats, one factor stands tall.

Why mega-tech growth are the best ‘value’ stocks in the market

They are six of the greatest businesses ever and should form part of the global portfolios of all investors. The market sees risk in inflation and valuations but the companies are positioned for outstanding growth.

How inflation impacts different types of investments

A comprehensive study of the impact of inflation on returns from different assets over the past 120 years. The high returns in recent years are due to low inflation and falling rates but this ‘sweet spot’ is ending.

How to manage the run down in your income in retirement

The first of five articles on modern retirement income products that aim for an increasing pension that lasts for life and on average should not decline in real terms. They are not silver bullets but worth a look.

Latest Updates

Superannuation

Retirement income promise relies on spending capital

The Government has taken the next step towards encouraging retirees to live off their capital, and from 1 July 2022 will require super funds - even SMSFs - to address retirement income and protect longevity risk.

Superannuation

How retirees might find a retirement solution in future

Superannuation funds need to establish a framework that offers retirees a retirement income solution that lasts a lifetime. It will challenge trustees to find a way to engage that their members understand and trust.

Investment strategies

Dividend investors, your turn is coming

Dividend payments from listed companies, depended on by many in retirement, have lagged the rebound in share prices over the past year. Better times are ahead but sources of dividends will differ from previous years.

Investment strategies

Four tips to catch the next 10-bagger in early-stage growth

Small cap investors face less mature companies with zero profit that need significant capital for growth. Without years of financial data to rely on, investors must employ creative ways to value companies.

Investment strategies

Investing in Japan: ready for an Olympic revival?

All eyes are on Japan and the opportunity to win for competing athletes. After disappointing investors for many years, Japan is also in focus for its value, diversification and the safe haven status of its currency.

Fixed interest

Five lessons for bond investors from the Virgin collapse

The collapse of Virgin Australia not only hit shareholders, but their bond investors received between 9 and 13 cents in the $1. A widely-diversified portfolio can tolerate losses better than a concentrated one.

Investment strategies

The 60:40 portfolio ... if no longer appropriate, then what is?

The traditional 60/40 portfolio might deliver only 1.5% above inflation in future without diversification benefits. Knowing an asset’s attributes rather than arbitrary definitions is better for investors.

Retirement

Two factors that can transform retirement investing

Retirees want better returns but they have limited appetite to dial up their risk exposure in order to achieve it. Financial advice and protection strategies in portfolios can enhance investment outcomes.

Sponsors

Alliances

© 2021 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.